▲ Peaking
Business
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
With Keytruda for First-Line Triple-Negative Breast Cancer
1 news trends Newsylist has tracked involving With Keytruda for First-Line Triple-Negative Breast Cancer — newest first.